Artificial Intelligence In Pharmaceutical Sciences

This cutting-edge reference book discusses the intervention of artificial intelligence in the fields of drug development, modified drug delivery systems, pharmaceutical technology, and medical devices development. This comprehensive book includes an overview of artificial intelligence in pharmaceutical sciences and applications in the drug discovery and development process. It discusses the role of machine learning in the automated detection and sorting of pharmaceutical formulations. It covers nanosafety and the role of artificial intelligence in predicting potential adverse biological effects. FEATURES Includes lucid, step-by-step instructions to apply artificial intelligence and machine learning in pharmaceutical sciences Explores the application of artificial intelligence in nanosafety and prediction of potential hazards Covers application of artificial intelligence in drug discovery and drug development Reviews the role of artificial intelligence in assessment of pharmaceutical formulations Provides artificial intelligence solutions for experts in the pharmaceutical and medical devices industries This book is meant for academicians, students, and industry experts in pharmaceutical sciences, medicine, and pharmacology.

The Era of Artificial Intelligence, Machine Learning and Data Science in the Pharmaceutical Industry examines the drug discovery process, assessing how new technologies have improved effectiveness. Artificial intelligence and machine learning are considered the future for a wide range of disciplines and industries, including the pharmaceutical industry. In an environment where producing a single approved drug costs millions and takes many years of rigorous testing prior to its approval, reducing costs and time is of high interest. This book follows the journey that a drug company takes when producing a therapeutic, from the very beginning to ultimately benefitting a patient’s life. This comprehensive resource will be useful to those working in the pharmaceutical industry, but will also be of interest to anyone doing research in chemical biology, computational chemistry, medicinal chemistry and bioinformatics. Demonstrates how the prediction of toxic effects is performed, how to reduce costs in testing compounds, and its use in animal research Written by the industrial teams who are conducting the work, showcasing how the technology has improved and where it should be further improved Targets materials for a better understanding of techniques from different disciplines, thus creating a complete guide

Major disruption worldover is due to AI, blockchain, 3D organ printing and others. Almost all the industries are being affected by AI. Health sector, particularly pharmaceutical sciences is also not an exception. The book has been designed to cover basics and role of AI in drug discovery, including clinical trials and other departments of health and pharmaceutical sciences. All the content has been compiled after referring and mining hundreds of latest and original first-hand updates from inventors, experts, organizations (who/which are engaged in drug discovery research directly or indirectly through AI) like Insilico, Google, Microsoft, INVIDIA, Novartis, Intel, IBM, Exscientia, Berg, Atomwise, XtalPi, Recursion, H2OAi, Recursion, BenevolentAI, Minds.ai, Deep Genomics, AiCure, Trials.ai, GNS Healthcare, MIT, Okwin, Flatiron, Syapse etc. It was unavoidable to explore content from websites and newspapers as authors were interested to cover latest content. All topics are explained in very simple language with clear aim and outcome using flow charts, tables and infographics. Professionals from medical, pharmacy, nursing and dental and medical imaging arena will find this book very useful. Students of all levels will find book very beneficial as few topics have been just touched, few have been shallow in complexity and rest are covered in detail. Full precautions have been exercised to address the needs of pharmacy students so that they can easily and effortlessly understand the subject matter of this book. Recent examples from various corporates, universities and daily life have found place in this unique book in a very explicit manner. At the end, questions have been added for the readers, mainly students. Authors are always open to suggestions, comments from our valuable readers. We wish you a happy reading......

A Handbook of Artificial Intelligence in Drug Delivery explores the use of Artificial Intelligence (AI) in drug delivery strategies. The book covers pharmaceutical AI and drug discovery challenges, Artificial Intelligence tools for drug research, AI enabled intelligent drug delivery systems and next generation novel therapeutics, broad utility of AI for designing novel micro/nanosystems for drug delivery, AI driven personalized medicine and Gene therapy, 3D Organ printing and tissue engineering, Advanced nanosystems based on AI principles (nanorobots, nanomachines), opportunities and challenges using artificial intelligence in ADME/Tox in drug development, commercialization and regulatory perspectives, ethics in AI, and more. This book will be useful to academic and industrial researchers interested in drug delivery, chemical biology, computational chemistry, medicinal chemistry and bioinformatics. The massive time and costs investments in drug research and development necessitate application of more innovative techniques and smart strategies. Focuses on the use of Artificial Intelligence in drug delivery strategies and future impacts Provides insights into how artificial intelligence can be effectively used for the development of advanced drug delivery systems Written by experts in the field of advanced drug delivery systems and digital health

Following significant advances in deep learning and related areas interest in artificial intelligence (AI) has rapidly grown. In particular, the application of AI in drug discovery provides an opportunity to tackle challenges that previously have been difficult to solve, such as predicting properties, designing molecules and optimising synthetic routes. Artificial Intelligence in Drug Discovery aims to introduce the reader to AI and machine learning tools and techniques, and to outline specific challenges including designing new molecular structures, synthesis planning and simulation. Providing a wealth of information from leading experts in the field this book is ideal for students, postgraduates and established researchers in both industry and academia.

Seminar paper from the year 2021 in the subject Computer Sciences - Artificial Intelligence, grade: 1,0, , language: English, abstract: During the past years, a continuously increasing number of corporations have decided to adopt Artificial Intelligence (AI) systems to improve their efficiency and reduce costs. This research paper aims to analyse the rise, applications, and developments of AI in the pharmaceutical and healthcare industry. Specifically, the employment of AI within the German multinational Bayer Pharmaceuticals is discussed, and further implementation suggestions are outlined. Furthermore, current opportunities, such as epidemic outbreak predictions and image recognition platforms for medication ingestion tracking, and challenges, for example legal issues and ethical challenges, are examined. The future role of AI systems in the pharmaceutical and healthcare industry can hardly be anticipated. Nevertheless, thus far these systems have represented a unique and tremendous asset within societies and companies, and it is most likely that in the course of time their role will be of always greater importance. Nowadays, organizations are defined by higher complexity, changing client demands, increased competition and adoption of new technologies. On the path towards an increased digitalization of economies and societies, the management of information and of knowledge, and the way people connect, collaborate and learn are drastically changing. As more and more possibilities for disruptive change are offered by digitalization, individuals and organizations need to redesign their leadership, innovation, knowledge processes and information practices.

Artificial intelligence (AI) and machine learning (ML) have emerged over the last decade as the cutting-edge technologies most expected to revolutionise the pharmaceutical R&D industry. Revolutionary developments in computer technology and the concomitant evaporation of earlier limits on the collection/processing of enormous amounts of data are contributing factors. Meanwhile, the price of developing and delivering new medicines to the market for patients has skyrocketed. Despite these challenges, the pharmaceutical sector is interested in AI/ML methods because of their predictivity, automation, and the efficiency boost that is projected as a result. Over the last 15–20 years, ML techniques have been increasingly used in the drug development process. Clinical trial design, conduct, and analysis are the most recent areas of drug research to see beneficial disruption from AI/ML. Due to the rising dependence on digital technology in the execution of clinical trials, the COVID-19 pandemic could further drive the employment of AI/ML in clinical trials. Getting through the associated buzzwords and noise is crucial as we progress toward a future where AI/ML is more integrated into R&D. Similarly crucial is the acknowledgement that the scientific method is still relevant for concluding evidence. By doing so, we can better iv evaluate the potential benefits of AI/ML in the pharmaceutical industry and make well-informed decisions on the best use. The purpose of this paper is to clarify important ideas, provide examples of their application, and provide a well-rounded perspective on how to best use AI/ML techniques in research and development.

Topic editor Alex Zhavoronkov is the founder of Insilico Medicine, a company specializing in AI research. He is also a professor at the Buck Institute for Research on Aging. All other Topic Editors declare no competing interests with regards to the Research Topic subject.